Consolidated Statements of Changes in Shareholders' Equity (Deficiency) - USD ($) |
Share Capital
Class B shares
|
Share Capital
Multiple Voting Shares
|
Share Capital
Subordinate Voting Shares
|
Share Capital
Exchangeable Shares
|
Treasury Stock |
Contributed surplus |
Accumulated other comprehensive (loss) income |
Deficit |
Subordinate Voting Shares |
Exchangeable Shares |
Total |
---|---|---|---|---|---|---|---|---|---|---|---|
Equity at beginning of period at Dec. 31, 2018 | $ 1,821,997 | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | $ 3,422,120 | $ (81,335,403) | $ (76,091,286) | ||
Number of shares outstanding at beginning of period at Dec. 31, 2018 | 3,696,486 | 0 | 0 | 0 | 0 | ||||||
Share exchange - Qualifying Transaction [Notes 1 and 4] | $ (1,821,997) | $ 1,821,997 | $ 248,411,016 | 248,411,016 | |||||||
Share exchange - Qualifying Transaction, shares | (3,696,486) | 3,696,486 | 13,474,000 | ||||||||
Share issuance - Qualifying Transaction [Note 4] | $ 125,421,479 | 125,421,479 | |||||||||
Share issuance - Qualifying Transaction, shares | 7,983,887 | ||||||||||
Stock-based compensation [Note 17] | 28,879,225 | 28,879,225 | |||||||||
Exercise of Rights, shares | 1,059,685 | 1,235,325 | |||||||||
Exercise of Warrants [Note 13] | $ 3,376,539 | 3,376,539 | |||||||||
Exercise of Warrants, shares | 298,200 | ||||||||||
Conversion of Exchangeable Shares, shares | 8,170,805 | ||||||||||
Share issuance - make-whole [Note 14] | $ 3,245,180 | 3,245,180 | |||||||||
Share issuance - make-whole, shares | 389,905 | ||||||||||
Repurchase of Subordinate Voting Shares [Note 13] | $ (66,205) | $ (245,469) | (311,674) | ||||||||
Repurchase of Subordinate Voting Shares, shares | (7,400) | (29,500) | |||||||||
Net loss | (164,179,604) | (164,179,604) | |||||||||
Foreign currency translation adjustment | (156,510) | (156,510) | |||||||||
Equity at end of period at Dec. 31, 2019 | $ 0 | $ 1,821,997 | $ 251,721,350 | $ 128,666,659 | $ (245,469) | 28,879,225 | 3,265,610 | (245,515,007) | 168,594,365 | ||
Number of shares outstanding at end of period at Dec. 31, 2019 | 0 | 3,696,486 | 14,824,485 | 8,373,792 | (29,500) | ||||||
Stock-based compensation [Note 17] | 31,156,759 | 31,156,759 | |||||||||
Exercise of Rights, shares | 175,640 | 1,235,325 | |||||||||
Exercise of Warrants [Note 13] | $ 105,957,197 | 105,957,197 | |||||||||
Exercise of Warrants, shares | 5,574,446 | ||||||||||
Conversion of Exchangeable Shares [Note 13] | $ 128,355,064 | $ (128,355,064) | |||||||||
Conversion of Exchangeable Shares, shares | 8,170,805 | (8,170,805) | 8,170,805 | ||||||||
Share issuance - make-whole [Note 14] | $ 3,765,927 | 3,765,927 | |||||||||
Share issuance - make-whole, shares | 614,515 | ||||||||||
Repurchase of Subordinate Voting Shares [Note 13] | $ (311,430) | (311,430) | |||||||||
Repurchase of Subordinate Voting Shares, shares | (34,300) | ||||||||||
Share issuance - combinations and acquisitions [Note 4] | $ 2,083,450 | $ 24,975,635 | 27,059,085 | ||||||||
Share issuance - combinations and acquisitions, shares | 128,265 | 1,310,041 | |||||||||
Net loss | (176,332,658) | (176,332,658) | |||||||||
Foreign currency translation adjustment | (9,030,828) | (9,030,828) | |||||||||
Equity at end of period at Dec. 31, 2020 | $ 0 | $ 1,821,997 | $ 488,117,061 | $ 29,053,157 | $ (556,899) | $ 60,035,984 | $ (5,765,218) | $ (421,847,665) | $ 150,858,417 | ||
Number of shares outstanding at end of period at Dec. 31, 2020 | 0 | 3,696,486 | 28,873,641 | 2,127,543 | (63,800) |